IRSA Inversiones y Representaciones S.A. releases material information regarding the dividend approved by the Shareholders’ Meeting held on October 5, 2023

Nvidia CEO aiming to set up base in Vietnam, Reuters reports

Utz Brands to host investor day

Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term...

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral...